Clinical trial
Clinical Efficacy of Chemotherapy Combined With Cytokine-induced Killer in Treatment of Patients With Colon Cancer
NCT03084809 is registered in ClinicalTrials.gov with China Meitan General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy of Chemotherapy Combined With Cytokine-induced Killer in Treatment of Patients With Colon Cancer
- Lead sponsor
- China Meitan General Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 6, 2012
- Completion date
- September 15, 2014
- Enrollment
- 46 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer, cytokine-induced killer cells, postoperative complications, survival